人工智能和系统生物学分析在干细胞研究和治疗开发中的应用
Thayna Silva-Sousa1,2,3,4, Júlia Nakanishi Usuda1,2,3,4,5,6, Nada Al-Arawe1,2,3,4,5,7,8
1BIH Center for Regenerative Therapies (BCRT), Charité Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health (BIH), Berlin 10117, Germany.
Stem cells translational medicine
|September 28, 2025
概括
系统生物学 (SysBio) 和人工智能 (AI) 可以加速干细胞治疗的翻译. 集成SysBio和AI分析多omics数据优化临床试验,改善患者的治疗结果和治疗开发.
科学领域:
- 再生医学是一种再生医学.
- 生物技术是生物技术.
- 计算生物学 计算生物学
背景情况:
- 干细胞研究已取得重大进展,但临床转化仍然缓慢.
- 来自产品开发和临床试验的数据利用效率低下,阻碍了干细胞治疗的实施.
- 需要解决干细胞疗法的有效临床转化的主要障碍.
研究的目的:
- 探索系统生物学 (SysBio) 和人工智能 (AI) 在克服干细胞治疗翻译障碍方面的作用.
- 突出SysBio和AI如何提高对产品和患者表现的理解.
- 引入由SysBioAI.AI支持的"精细临床翻译的代循环"概念.
主要方法:
- 总结SysBio和AI在干细胞研究和治疗开发中的贡献.
- 利用细胞产品分析,临床试验设计和患者监测方面的进步.
- 使用SysBioAI.使用患者和临床试验结果分析大规模的多omics数据.
主要成果:
- SysBioAI 能够快速,综合分析复杂的生物数据.
- "精细临床翻译的代循环"概念促进了适应性发展周期.
- 通过生物标志物识别,SysBioAI支持以患者为中心的安全性和有效性评估.
结论:
- 集成的SysBioAI应用程序优化了临床试验设计和结果.
- 通过识别患者特异性反应,SysBioAI提高了治疗的安全性和有效性.
- 这种方法激发了以患者为中心,适应性强的下一代深度医学策略.
相关概念视频
EPS and iPS Cells in Disease Research
3.4K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.4K
Stem Cell Culture
6.0K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
6.0K
iPS Cell Differentiation
3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K


